Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CHINOM prevention trial in high-normal blood pressure with cardiovascular risk factors
ChiCTR-PRC-08000217Phase 4Completed
- Sponsor
- China Resources Double-Crane Pharmaceutical
- Start
- Jan 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of telmisartan, indapamide, Beijing 0 and Placebo-COD Research Private Ltd in hypertension (HTN) and cardiac morbidity (4 arms), sponsored by China Resources Double-Crane Pharmaceutical. Primary endpoints: Combined cardiovascular events, New onset hypertension and 1 more. Started Jan 2008; status: completed.
02
Drugs
telmisartanindapamideBeijing 0Placebo-COD Research Private Ltd
03
Conditions
hypertension (HTN)cardiac morbidity
Beyond the preview
Go deeper on ChiCTR-PRC-08000217.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-PRC-08000217.